rescinnamine (Moderil)

08/15/1958 - "[Rescinnamine in the treatment of benign essential arterial hypertension; preliminary trial]."
11/15/1970 - "[Value of a thiazic-antialdosterone-rescinnamine association in the treatment of arterial hypertension (42 cases)]."
01/31/1961 - "[Action of rescinnamine, Rauwolfia serpentina alkdloid, on renal hemodynamics in patients with arterial hypertension]."
12/24/1960 - "Rescinnamine in treatment of hypertension in hospital clinic and in general practice."
05/01/1956 - "The response to rescinnamine administered parenterally and orally for the treatment of hypertension."

01/01/2013 - "Computational and synthetic studies towards improving rescinnamine as an inducer of MSH2-dependent apoptosis in cancer treatment."

03/13/1958 - "[Chemistry & pharmacology of a new ganglion blocking agent, plegarol, and the hypotensive agent, raupyrol, in combination with rescinnamine]."

10/01/1977 - "In the experiments of the inhibitory effects of the central actions such as ptosis, hypothermia, decrease in motor ability, potentiation of hexobarbital and taming, reserpine was found to be the most potent followed by rescinnamine and CD-3400, respectively. "

01/01/2015 - "Plants from the Apocynaceae family have been traditionally used in the treatment of age-related brain disorders Methods and Results: Two new indole alkaloids, rauvolfine C (1) and 3-methyl-10,11-dimethoxy-6-methoxycarbonyl-β-carboline (2), along with five known, macusine B (3), vinorine (4), undulifoline (5), isoresrpiline (6) and rescinnamine (7) were isolated from the bark of Rauvolfia reflexa. "